Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy

Table 2

Metabolic and renal parameters in control and type 2 diabetic subjects. BMI: body mass index, SBP: systolic blood pressure, and DBP: diastolic blood pressure.

	Control	Diabetes	Diabetes + RI
𝑁	5	15	7
HbA1c (%)	5.6±0.4	8.1±1.2^∗	7.4±0.8^∗
BMI (kg/m^2)	34.5±4.9	39.9±6.8	39.9±6.6
AER (μg/min)	11.7±5.9 (2.9−32.9)	21.9±21.7 (3.8−86.6)	356.7±667.7 (3.3−1998.0)
iGFR (mL/min/1.73 sqm)	131.0±28.4	114.2±16.8	93.0±38.6^†
SBP (mmHg)	135.0±7.9	143.3±14.8	132.1±16.6
DBP (mmHg)	86.0±8.9	86.7±9.8	73.6±14.4^†
Circulating CML (μmol/mol lysine)	955.6±129.7	916.2±207.7	885.8±119.3

^∗𝑃<.05 versus control, ^†𝑃<.05 versus diabetes, ^§𝑃=.07 (ns) versus diabetes.